For example, ginsenosides can trigger ferroptosis in GBM models [55], while berberine engages mitochondrial apoptosis alongside NF-κB suppression [56], illustrating how anti-inflammatory agents intersect resistance biology. The gene discussed is NFKB1; the disease is glioblastoma.